Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rituximab in Active Ulcerative Colitis

This study has been completed.
Sponsor:
Collaborators:
Hoffmann-La Roche
University of Liverpool
Information provided by (Responsible Party):
Jonathan Michael Rhodes, Royal Liverpool University Hospital
ClinicalTrials.gov Identifier:
NCT00261118
First received: November 29, 2005
Last updated: November 5, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):